Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

44.1K
Overview
44.1K
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

108
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
108
Immunological Memory01:23

Immunological Memory

549
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
549

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Performance Comparison of Rapid and Native Barcoding Methods for Oxford Nanopore Sequencing of Poliovirus Viral Protein 1 (VP1) Amplicons.

Journal of virological methods·2026
Same author

Complete genome sequences of eight poliovirus Sabin 2-derived and five novel oral poliovirus 2-derived circulating vaccine-derived poliovirus (CVDPV) genomes with single-end recombination from Botswana, 2022-2023.

Microbiology resource announcements·2026
Same author

Diabetes educational interventions in care homes: a scoping review.

BMC medical education·2026
Same author

Effectiveness of Music Therapy for Delirium in Acute Hospital Settings: A Scoping Review.

Nursing reports (Pavia, Italy)·2026
Same author

Seroprevalence of dengue virus antibodies among multiple species of non-human primates in Senegal suggests that sylvatic dengue virus is maintained in non-primate reservoirs in this region.

PLoS neglected tropical diseases·2026
Same author

Correction: Wassilak et al. Impediments to Progress Toward Polio Eradication During 2014-2024: Effectively Addressing the Current Challenges. <i>Vaccines</i> 2025, <i>13</i>, 1060.

Vaccines·2025

Related Experiment Video

Updated: Jun 10, 2025

Particle Agglutination Method for Poliovirus Identification
07:06

Particle Agglutination Method for Poliovirus Identification

Published on: April 20, 2011

15.3K

Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, January 2023-June 2024.

Apophia Namageyo-Funa, Sharon A Greene, Elizabeth Henderson

    MMWR. Morbidity and Mortality Weekly Report
    |October 17, 2024
    PubMed
    Summary

    Global polio outbreaks from circulating vaccine-derived polioviruses (cVDPVs) increased, predominantly in Africa. Timely, high-quality responses are crucial to control outbreaks and stop transmission by boosting population immunity.

    More Related Videos

    Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
    07:44

    Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

    Published on: May 12, 2023

    1.1K
    Expression and Purification of Virus-like Particles for Vaccination
    06:17

    Expression and Purification of Virus-like Particles for Vaccination

    Published on: June 2, 2016

    21.8K

    Related Experiment Videos

    Last Updated: Jun 10, 2025

    Particle Agglutination Method for Poliovirus Identification
    07:06

    Particle Agglutination Method for Poliovirus Identification

    Published on: April 20, 2011

    15.3K
    Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
    07:44

    Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

    Published on: May 12, 2023

    1.1K
    Expression and Purification of Virus-like Particles for Vaccination
    06:17

    Expression and Purification of Virus-like Particles for Vaccination

    Published on: June 2, 2016

    21.8K

    Area of Science:

    • Global Health Security
    • Infectious Disease Epidemiology
    • Vaccine-Preventable Diseases

    Background:

    • Circulating vaccine-derived polioviruses (cVDPVs) pose a significant risk for polio outbreaks and transmission, especially in under-vaccinated populations.
    • cVDPVs can emerge from oral poliovirus vaccines and spread asymptomatically, leading to paralytic polio cases.
    • Previous reports have highlighted the ongoing challenge of cVDPV emergence and spread globally.

    Purpose of the Study:

    • To describe global polio outbreaks caused by cVDPVs between January 2023 and June 2024.
    • To update the understanding of the geographical distribution and characteristics of cVDPV outbreaks.
    • To identify factors contributing to persistent transmission and international spread.

    Main Methods:

    • Utilized data from the World Health Organization Polio Information System.
    • Analyzed data from the Global Polio Laboratory Network.
    • Described and categorized cVDPV outbreaks based on type, location, and duration.

    Main Results:

    • Detected 74 cVDPV outbreaks in 39 countries, with a majority in Africa.
    • Identified 47 new outbreaks, with cVDPV type 2 (cVDPV2) being the most prevalent.
    • Observed persistent transmission (>1 year) in 15 countries, with notable spread from Nigeria and Somalia due to security issues and delayed/low-quality response campaigns.

    Conclusions:

    • Effective control of cVDPV outbreaks requires prompt, high-quality response campaigns following confirmation.
    • Sustained international spread is linked to delayed and suboptimal outbreak response efforts.
    • Achieving the cessation of all cVDPV transmission necessitates increasing population immunity by addressing barriers to child vaccination.